Clinical Trials
3 trialsNCT06416852 2024-05-16
Clinical Study of 18F-Alfatide Injection PET/CT
Yantai LNC Biotechnology Singapore PTE. LTD.
Phase 3 Not yet recruiting
NCT02879617 2024-01-05
A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients
Academic Thoracic Oncology Medical Investigators Consortium
Phase 2 Completed
NCT04667312 2023-10-02
CODAK
AstraZeneca
Completed